Atlas Trials

Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

Clinical trial NCT00588731 · COMPLETED

Trial details

NCT number
NCT00588731
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2009-02-01
Primary completion
2013-12-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.